✦ LIBER ✦

Molecular variants of HPV-16 associated with cervical cancer in Indian population

✍ Scribed by M.R. Pillai; R. Hariharan; Janki Mohan Babu; S. Lakshmi; S.V. Chiplunkar; M. Patkar; H. Tongaonkar; K. Dinshaw; R.S. Jayshree; B.K.M. Reddy; M. Siddiqui; Soma Roychoudury; Baisakhi Saha; P. Abraham; M. Gnanamony; A. Peedicayil; J. Subhashini; T.S. Ram; Bindu Dey; C. Sharma; S.K. Jain; N. Singh

Publisher: John Wiley and Sons
Year: 2009
Tongue: French
Weight: 214 KB
Volume: 125
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.24322

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Human papilloma virus is a causative factor in the etiology of cervical cancer with HPV16 being the most prevalent genotype associated with it. Intratype variations in oncogenic E6/E7 and capsid L1 proteins of HPV 16 besides being of phylogenetic importance, are associated with risk of viral persistence and progression. The objective of this multicentric study was to identify HPV‐16 E6, E7 and L1 variants prevalent in India and their possible biological effects. Squamous cell cervical cancer biopsies were collected from 6 centres in India and examined for the presence of HPV 16. Variants of HPV‐16 were characterized by full length sequence analysis of L1, E6 and E7 genes in 412 samples. Similar distribution of the variants was seen from the different centres/regions, with the European variant E350G being the most prevalent (58%), followed by American Asian variant (11.4%). Fifty six changes were seen in E6 region, 31 being nonsynonymous. The most frequent being L83V (72.3%), Q14H (13.1%) and H78Y (12.1%). Twenty‐nine alterations were seen in E7 region, with 12 being nonsynonymous. The most frequent being F57V (9%). L1 region showed 204 changes, of which 67 were nonsynonymous. The most frequent being 448insS (100%), and 465delD (100%), H228D (94%), T292A (85%). The identified variants some new and some already reported can disrupt pentamer formation, transcriptional regulation of the virus, L1 protein interface interaction, B and T cell epitopes, p53 degradation, and thus their distribution is important for development of HPV diagnostics, vaccine, and for therapeutic purpose. © 2009 UICC

📜 SIMILAR VOLUMES

Association of HPV16 E6 variants with di

Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population

✍ Rosemary E. Zuna; William E. Moore; Rebecca P. Shanesmith; S. Terence Dunn; Soph 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 93 KB

## Abstract It has been suggested that DNA sequence variants of HPV16 contribute to differences in the behavior of individual cervical lesions. To address this question, we have analyzed the association of HPV16 variants with diagnostic severity in 354 HPV16‐positive Oklahoman women. HPV16 variant

HLA class II alleles associated with inf

HLA class II alleles associated with infection by HPV16 in cervical cancer in situ

✍ Anna H. Beskow; Agnetha M. Josefsson; Ulf B. Gyllensten 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 64 KB 👁 1 views

HLA class II alleles have been associated with an increased risk of developing cervical cancer through infection with oncogenic forms of human papilloma virus (HPV). We have examined the association of variation at the DRB1 and DQB1 loci with HPV16 infection and risk of development of cervical cance

Detection of HPV 16 and HPV 18 DNA in th

Detection of HPV 16 and HPV 18 DNA in the blood of patients with cervical cancer

✍ Patti Kay; Bruce Allan; Lynette Denny; Margaret Hoffman; Anna-Lise Williamson 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 1 views

Persistent infection of the uterine cervix with high-risk human papillomaviruses (HPV) is causally associated with cancer of the cervix. A few studies have reported the presence of HPV DNA in the blood of women with cervical neoplasia. The aim of this study was to determine if HPV DNA could be detec

Uniform distribution of HPV 16 E6 and E7

Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer

✍ Ingo Nindl; Knuth Rindfleisch; Beatrix Lotz; Achim Schneider; Matthias Dürst 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 160 KB 👁 2 views

High-risk human papillomaviruses (HPV), particularly HPV 16, are associated with invasive cervical cancer (ICC), and persistent high-risk HPV infection is considered to be a marker for progressive cervical intra-epithelial neoplasia (CIN). However, most high-risk, HPV-infected, pre-cancerous lesions

Improved stage at diagnosis of cervical

Improved stage at diagnosis of cervical cancer with increased cancer awareness in a rural Indian population

✍ Kasturi Jayant; R. S. Rao; B. M. Nene; P. S. Dale 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 466 KB

As part of its strategy to identify cancer cases in a rural population, the cancer registry of Barshi, India, has developed a methodology which includes education of the population about likely symptoms 'of cancer, and motivation of symptomatic individuals to undergo medical investigation. Patients

Characterization of humoral immune respo

Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers

✍ Miriam Reuschenbach; Tim Waterboer; Keng-Ling Wallin; Jens Einenkel; Joakim Dill 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 241 KB

## Abstract The cellular tumor suppressor p16 is strongly overexpressed in cervical cancers and precancers. We have previously demonstrated that infiltrating T lymphocytes reactive against p16 can be found in cervical cancer patients. Here, we analyzed whether p16 induces humoral immune responses.